HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 01/15/2013 -- Express, Inc. (NYSE:EXPR) increased 1.2% or 17 cents to $14.06 after the specialty retail apparel chain lifted outlook for the fourth quarter and full year 2012. For the fourth quarter, the company expects comparable sales to range from flat to up 1% and net income in the range of $61 million to $63 million or 72 cents to 74 cents a diluted share from the previous guidance of $53 million to $58 million or 62 cents to 68 cents per diluted share.
How Should Investors Trade EXPR After The Recent Volatile Moves? Find Out Here
Santarus, Inc. (NASDAQ:SNTS) said the U.S. Food and Drug Administration has approved its treatment for a chronic inflammatory bowel disease as the specialty biopharmaceutical company also said it expects to meet or exceed its previous expectations for full-year earnings and revenue. Santarus also offered revenue guidance for 2013 above analysts’ expectations. Shares rose 5.9% to $11.94 premarket.
How Should Investors Trade SNTS After The Recent Momentum? Find Out Here
QLogic Corp. (NASDAQ:QLGC) is currently trading at $10.9 up 7.1% in pre-market on 25300 shares traded. QLGC is trading 8.49% above its 50 day moving average and -17.76% below its 200 day moving average. QLGC is -46.42% below its 52-week high and 17.96% above its 52-week low. QLGC's PE ratio is 11.57 and their market cap is $943.89M.
Is QLGC Showing Any Sign of Buy At The Current Market Price? Find Out Here
Pluristem Therapeutics Inc. (NASDAQ:PSTI) is currently trading at $3.41 up 5.3% in pre-market on 7000 shares traded. PSTI is trading -4.57% below its 50 day moving average and 1.05% above its 200 day moving average. PSTI is -35.20% below its 52-week high and 60.40% above its 52-week low.
Can PSTI Extend Gain? If Yes, How Far It Can Go? Find Out Here
Radisys Corp (NASDAQ:RSYS) announced that, based upon preliminary results which are subject to final review and audit, it expects fourth quarter revenue near the high end of the guidance range provided on October 30, 2012 and positive non-GAAP earnings per share compared to a previous guidance range of ($0.06) to breakeven. Strong Software-Solutions revenues enabled better than expected profitability.
How Should Investors Trade RSYS Now? Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)